Abstract PR017: Advancing a comprehensive pediatric liquid biopsy platform, LBSeq4Kids, using Illumina 5-Base technology
LBSeq4Kids is a CAP/CLIA-certified pediatric liquid biopsy (LB) platform developed at the Center for Personalized Medicine at CHLA that combines low-pass whole-genome sequencing (WGS) for the detection of copy number alterations (CNAs) and a targeted sequencing panel for the detection of variants and gene fusions fro...